Okabena Investment Services’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-18
Closed -$2.76K 205
2023
Q1
$2.76K Buy
18
+7
+64% +$1.16K ﹤0.01% 155
2022
Q4
$1.98K Buy
+11
New +$1.8K ﹤0.01% 191
2021
Q4
Sell
-2,550
Closed -$981K 200
2021
Q3
$981K Buy
+2,550
New +$940K 0.52% 53

Other funds holding MRNA

Okabena Investment Services's MRNA Position: Q2 2023 in Review

Okabena Investment Services sold out of Moderna (MRNA) in Q2 2023, closing a stake of 18 shares — an estimated $2.76K sold.

Okabena Investment Services first reported a position in MRNA in Q3 2021 and held it in 3 quarters. The position peaked at $981K in Q3 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Okabena Investment Services reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Okabena Investment Services sold 18 Moderna shares in Q2 2023, an estimated $2.76K.
  • Okabena Investment Services first reported a position in Moderna in Q3 2021 and held it in 3 quarters.
  • Okabena Investment Services's Moderna position peaked at $981K in Q3 2021.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Okabena Investment Services's 13F filing for Q2 2023, filed 14 Aug 2023.